Great Basin Confirms Separation of Publicly Traded Units

Great Basin Scientific, Inc. GBSN, a molecular diagnostics company, confirmed today that, the Company's publicly traded unit GBSNU has separated into its component parts of eight Series C Warrants and one share of Series E Convertible Preferred Stock. In connection with the separation of the Units, the Units were delisted from The Nasdaq Capital Market effective August 25, 2015. The common stock of the Company GBSN will remain listed on The Nasdaq Capital Market and is unaffected by the delisting of the Units. For instructions and forms regarding the conversion of the Series E Convertible Preferred Stock or the exercise of the Series C Warrants, please see the investor relations portion of the Company's website at http://client.irwebkit.com/gbscience.